Victoza and Revatio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Revatio (sildenafil citrate). Common drug interactions include pain in extremity among females and cholestasis among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Revatio. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.



On Aug, 05, 2026

47 people who take Victoza and Revatio together, and have interactions are studied.

Victoza and Revatio drug interactions.

What are the common drug interactions of Victoza and Revatio, by gender? *:

female:

  1. Pain in extremity
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Pulmonary thrombosis (scarring in the lungs)
  4. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  5. Sinusitis (inflammation of sinus)
  6. Uterine cancer
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Fall
  10. Pneumonia

male:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatic failure (liver failure)
  3. Pneumonia
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Death
  7. Fatigue (feeling of tiredness)
  8. Haemorrhage intracranial (bleeding within the skull)
  9. Poor venous access
  10. Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the common drug interactions of Victoza and Revatio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Tenderness (pain or discomfort when an affected area is touched)
  2. Vision blurred
  3. Wheezing (a high-pitched whistling sound made while you breath)
  4. Costochondritis (chest wall pain)
  5. Fatigue (feeling of tiredness)
  6. Head injury
  7. Local swelling (swelling at the site of some application of substance or injury)
  8. Menstruation irregular
  9. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  10. Pelvic pain

30-39:

n/a

40-49:

n/a

50-59:

  1. Asthenia (weakness)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Muscle spasms (muscle contraction)
  6. Anaemia (lack of blood)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Constipation
  9. Faeces discoloured
  10. Haematuria (presence of blood in urine)

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Nausea (feeling of having an urge to vomit)
  3. Dyspnoea (difficult or laboured respiration)
  4. Pain
  5. Fall
  6. Overdose
  7. Stress
  8. Asthma
  9. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 38 people, 80.85%
  2. Type 2 Diabetes: 21 people, 44.68%
  3. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 19 people, 40.43%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Revatio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Victoza and Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Revatio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on liraglutide and sildenafil citrate (the active ingredients of Victoza and Revatio, respectively), and Victoza and Revatio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: